Abbott will acquire AMO, a leader in ophthalmic care, for $22 per share in cash, for a total transaction value of approximately $2.8 billion.
"Through superior vision care technologies and service, AMO has established itself as a leader in this multi-billion dollar medical device segment," said Miles White, chairman and CEO of Abbott in the press release. "With AMO, Abbott is enhancing and strengthening its diverse mix of medical device businesses and gaining a leadership position in another large and growing segment."
Read the press release about the Abbott acquisition of AMO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
